EPAM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
EPAM Systems Inc is not a strong buy at the moment for a beginner investor with a long-term strategy. Despite solid financial performance in Q4 2025, the stock is experiencing significant downward pressure due to a cautious 2026 outlook and negative market sentiment. Technical indicators suggest oversold conditions, but no proprietary trading signals indicate a strong buy opportunity. It is advisable to wait for stabilization or clearer positive catalysts before investing.
The stock is in a strong downward trend with a -17.01% regular market change and -21.55% pre-market change. The RSI is at 18.131, indicating oversold conditions. The MACD histogram is -4.92, below 0, and negatively expanding, showing bearish momentum. Key support is at $140.115, with resistance at $164.964. The stock is trading near its support level but lacks bullish reversal signals.
Q4 2025 financials showed revenue growth of 12.8% YoY and EPS growth of 10%. The company is making progress in scaling its GenAI business and integrating recent M&A activities.
The stock dropped 20.6% following a cautious 2026 revenue outlook, disappointing investors. Gross margin declined by 1.55% YoY. Analysts have mixed ratings, with some maintaining Neutral or Hold positions. No significant hedge fund or insider trading trends were observed.
In Q4 2025, revenue increased by 12.75% YoY to $1.41 billion, net income rose by 5.86% YoY to $109.35 million, and EPS grew by 10% YoY to $1.98. However, gross margin dropped to 27.88%, down 1.55% YoY, indicating some profitability concerns.
Analysts have mixed ratings. Citi raised the price target to $225 but maintained a Neutral rating. TD Cowen raised the price target to $243 with a Buy rating, citing gradual improvement in IT spending. Truist initiated coverage with a Hold rating and a $220 price target, highlighting the company's transition phase and subdued growth.
